News
IDIBELL receives 1.2 million euros in grants to promote scientific research and its transfer
Funded projects address different areas of health, from precision radiotherapy to the search for therapies for breast cancer and other diseases.
Funded the UPDATE project that will promote the leadership of IDIBELL in Horizon Europe
The Ministry of Science and Innovation and the State Research Agency, in the call for Grants for the Preparation and Management of European Projects, have financed the project “UPDATE – SUPporting IDIBELL reseArchers To succeed in Horizon Europe”.
A receptor until now considered a death promoter in tumor cells could induce the growth of lung cancer
A study by IDIBELL and the University of Amsterdam published in the journal Cell Death and Disease shows that TRAIL protein receptors induce the expression of IL-8, a protein that promotes tumor development and angiogenesis in lung tumors.
Does everything cause cancer? Beliefs about cancer among anti-vaxxers and flat earthers: a call to combat misinformation
A team from IDIBELL and the Catalan Institute of Oncology has published the results of a survey that shows that anti-vaccine groups, flat earthers or defenders of the existence of reptilians recognize less the actual cancer causes, and therefore, identify false myths as carcinogens.
Almost 90% of deaths and illnesses in Spain were due to non-infectious diseases such as heart disease, stroke, COPD, Alzheimer’s, and lung cancer
Based on the ‘Global Burden of Disease’ 2019, national researchers led by CIBER, and other Spanish and North American centers, including IDIBELL and ICO, draw a detailed picture of the health in Spain before the pandemic and offer a vision of the future trends.
Researchers develop a model that predicts the COVID-19 clinical evolution at the hospital admission point
A joint project from the UPC, the UB, the HUB, and IDIBELL studied the probability of suffering severe pneumonia, needing ventilation, or even dying during hospital admission due to COVID-19. As a result of the statistical models created, based on data from more than 5,000 patients admitted to five hospitals in different pandemic waves, they developed a web application for the early identification of potentially high-risk COVID-19 patients and the prediction of the disease course.
hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases
This support will help to develop and characterize a new immunomodulatory compound discovered by the IDIBELL group led by Dr. Josep Maria Aran.
CAC, IDIBELL and the Bellvitge University Hospital culminate the study What do you bet? about the risks of video games and gambling
The didactic material presented a year ago has been reviewed after its application as a pilot test with 3rd and 4th ESO students at the Virolai School and the Bellvitge Institute. The study concludes that educational programs prevent addictions to video games and gambling.
Researchers identify an effective therapeutic strategy against a subtype of melanoma currently with no treatment
Researchers have observed that, in the absence of glucose, tumor cells become sensitive to treatment with sorafenib, a drug that was approved years ago for other indications.